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Human placental development 
The human placenta is a villous placenta; the structur-
al and functional unit of the human placenta is the
chorionic villous which becomes apparent in its defin-
itive structure as early as day 21 of pregnancy [1] (Fig.
1). After nidation, the trophoblast differentiates in two
ways: the villous and the extra-villous trophoblast. In
the villous phenotype, the cytotrophoblastic cells (CT)
of the floating villi (in the intervillous space) remain
attached to the villous basement membrane, forming 
a monolayer of epithelial cells. These cells proliferate
and differentiate, by fusion, to form a syncytiotro-
phoblast that covers the entire surface of the villus
(Fig. 1). This multinucleated syncytiotrophoblast is
regenerated along pregnancy by a continuous turnover
process including proliferation of mononuclear CT fol-
lowed by the induction of early stages of apoptosis and
fusion of these CT into ST. Apoptotic progression in
the ST leads to the accumulation of condensed nuclei
into syncytial knots and the shedding of these aggre-
gates into the intervillous spaces. This membrane
fusion process is complex and involves different fac-
tors [see for review 2]. Among them endogenous retro-
viral envelope proteins (syncytins), are specifically
expressed in the trophoblast; syncytin 1, the envelop
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Abstract: The human placenta is characterized by the intensity of the trophoblast invasion into the uterus wall and the speci-
ficity of its hormonal functions. Placental hormones are required for the establishment and maintenance of pregnancy, adap-
tation of the maternal organism to pregnancy and fetal growth. In the early placenta at the maternofetal interface, the human
trophoblast differentiates along two pathways: 1/ the villous trophoblast pathway including the cytotrophoblastic cells which
differentiate by fusion to form the syncytiotrophoblast that covers the entire surface of the villi; 2/ the extravillous tro-
phoblast pathway. The cytotrophoblastic cells of the anchoring villi in contact with the uterus wall proliferate and then
migrate into the decidua and the myometrium but also participate to the remodeling of the spiral arteries. During the first
trimester of pregnancy the spiral arteries are plugged by trophoblastic cells, allowing the development of the fetoplacental
unit in low oxygen environment. At this stage of pregnancy the extravillous trophoblast secretes a large amount of hormones
such as particular hyperglycosylated forms of hCG directly involved in the quality of the placentation. At 10-12 weeks of
pregnancy, the trophoblastic plugs are progressively dislocated and the syncytiotrophoblast starts to bath in maternal blood.
It secretes the major part of its polypeptide hormones in maternal circulation taking over the maternal metabolism in order
to increase the energetic flux to the fetus. As example the placental GH (growth hormone) secreted continuously by the syn-
cytiotrophoblast is directly involved in the insulino-resistance of pregnancy. Capturing the cholesterol from the maternal
lipoproteins, the syncytiotrophoblast synthesizes also large amount of progesterone essential for the uterine quiescence.
Deprived of cytochrome P450 17α-hydroxylase-17:20 lyase, it uses the maternal and fetal adrenal androgens to synthesize
estrogens. The differentiation and hormonal functions of the human trophoblast are regulated by the environmental O2 and
reflect mammalian evolution. 
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glycoprotein of HERVW retrovirus is directly
involved in trophoblast fusion and differentiation [3].
In the extravillous phenotype, the cytotrophoblastic
cells of the anchoring villi in contact with the uterine
wall proliferate, detach from the basement membrane
and aggregate into multilayered columns of non-
polarised cells that rapidly invade the uterus wall. This
trophoblastic invasion is confined to the endometrium,
the first third of the myometrium, and the associated
spiral arterioles. This invasion process is associated
with complete remodeling of the spiral artery wall,
leading to the disappearance of the muscle layer and
replacement of endothelial cells by trophoblasts [4].
This trophoblastic endovascular and perivascular inva-
sion is of major importance for feto-placental physiol-
ogy: intra-arterial plugs of endovascular trophoblasts
prevent, until the twelfth week of gestation, access of
maternal blood to the intervillous space and therefore
protect the conceptus from excessively high oxygen
levels during this very critical stage of development
(Fig. 2) [5,6]. 
As illustrated in Fig. 3 primary culture of tro-
phoblast cells are usefull models to study human tro-
phoblast differentiation. Extravillous cytotrophoblastic
cells can be isolated from first trimester anchoring
chorionic villi. When plated on extracellular matrix
substrates they recapitulate the differentiation process
that lead to invasion in vivo [7]. Primary culture cells
have also thrown light on human villous trophoblast
differentiation. Isolated villous cytotrophoblast from
early and term placenta adhere to plastic dish, aggre-
gate and fuse together to form a non proliferative mult-
inucleated syncytiotrophoblast which expresses spe-
cific hormonal production [8]. Different permanent
trophoblast cell lines are also available. They offer an
easy accessible model to study some aspects of gene
expression and regulation in cells derived from tro-
phoblast. However these highly proliferative cell lines
do not reflect necessarily the complex phenotype of
villous or extravillous trophoblast [9]. Therefore cau-
tions must be taken before extrapolating results
obtained in these cell lines to normal trophoblast. 
Human placental hormonal functions 
The human placenta is characterized by the intensity
and specificity of its hormonal functions. Indeed the
human trophoblast secretes many polypeptide hor-
mones and a large amount of steroid hormones. The
polypeptide hormones are primarily: hCG (human
chorionic gonadotropin), hPL (human placental lacto-
gen) or hCS ( human somatomammotropic hormone)
and placental GH (growth hormone). The glycoprotein
hormone hCG, is the key hormone of human pregnan-
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Fig. 1 Left panel. Scheme of human chorionic villi. Right panel Immunoshistochemistry analysis of trophoblast differentiation in the
implantation site of early human placenta. Paraffin-embedded sections of an implantation site (placenta and myometrium) at 16 weeks of
pregnancy was obtained from the Department of Pathology CHR La Citadelle, Liege. Hysterectomy was performed because of cervical
carcinoma stage IIa diagnosed at 16 weeks of gestation. Samples were fixed in 4 % formalin for 4 to 12 h at room temperature. Use of
these biological samples, were approved by local ethical committee. Sections were stained for cytokeratine 07 to identify trophoblastic
cells. IS= intervillous space, PEVCT= proliferative extravillous cytotrophoblastic cells, IEVCT= invasive extravillous cytotrophoblastic
cells, ST= syncytiotrophoblast.
cy [see for review 10]. It behaves like a super agonist
of LH allowing the transformation of cyclic ovary cor-
pus luteum, in gravidic corpus luteum, ensuring the
maintenance of ovarian progesterone secretion during
the first 6 weeks of pregnancy. HCG is made up of two
subunits, an alpha subunit and a beta subunit. The
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Fig. 2. Immunohistochemistry analysis of
trophoblast invasion and arteries remod-
eling. Sections were stained for cytoker-
atine 07 to identify trophoblastic cells. A
and B: Periarterial invasion. C and D:
endovascular invasion. 
Fig. 3 In vitro models to study human placental cells and trophoblast
differentiation. From the same early placenta chorionic villi sequential
enzymatic digestions and purification allow to isolate: 1/ extravillous
trophoblastic cells which require a matrix to survive and are invasive
cells as tested in a Boyden chamber assay, 2/ villous trophoblastic cells
which adhere to plastic dishes and fuse to form a syncytiotrophoblast
3/ placental fibroblasts from the mesenchymal core of the villi. Extrav-
illous trophoblastic cells have been immortalized by T /t of SV40 lead-
ing to the HIPEC 65 cell line [25].
alpha subunit is the same in the other glycoproteic hor-
mones (FSH, LH, TSH). The alpha subunit is made up
of 92 amino acids with two N-glycosylation sites. It is
encoded by only one gene on the chromosome 6q21.1-
23. The beta subunit is made up of 145 amino acids
with two sites of N-glycosylation and 4 sites of O-gly-
cosylation. It is encoded by a whole set of genes, six
genes beta, a pseudogene CCG beta and a gene LH
beta on the chromosome 19q13.3. These genes CG
beta evolved by duplication from the gene beta LH and
are controlled differently on the level of their promot-
er. Compared with LH, the 31 additional amino acids
in position C-terminal of hCG, and hCG very high gly-
cosylation level allow its intracellular traffiking
towards the apical membrane of the syncytiotro-
phoblast, its secretion directly in maternal circulation
and its prolonged half-life [11]. By an autocrine and
paracrine mechanism, hCG plays an essential role in
trophoblast differentiation. It stimulates in vitro differ-
entiation of the cytotrophoblastic cells into syncy-
tiotrophoblast [12,13]. Recently hCG was character-
ized as a new angiogenic factor involved in the estab-
lishment and the development of the human placenta
[14]. Several recent studies have demonstrated the
importance of the glycosylation state of hCG, which
varies with the differentiation stage of the trophoblast
as well as the stage of pregnancy [15]. Indeed hCG
secreted by the early invasive trophoblast, likely
HhCG (hyperglycosylated hCG), but not by the syncy-
tiotrophoblast, promotes trophoblast invasion [16]. In
addition, trophoblast cells displaying chromosome 21
trisomy [17] produce abnormal glycosylated forms of
hCG with low biological activity. It should be noted
that no CG beta genes have been found in mice. It is
known for many years that the syncytiotrophoblast
secretes in the maternal compartment very large
amount of hCS or hPL. This hormone is also found in
fetal blood but in much smaller amount than in mater-
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Fig. 4 Scheme of placental steroidogenesis. E1=
estrone, E2=estradiol, E3=estriol, P5=preg-
nenolone, P4=progesterone, DHA=dehydroepian-
drosterone, MLN64=metastatic lymph node 64. 
nal blood. The increase in the secretion of hPL during
pregnancy follows the evolution of the placental mass,
and more particularly the syncytiotrophoblast mass,
site of its synthesis. Its real physiological role remains
to be elucidated. Indeed normal pregnancies have been
described in the absence of hPL secretion. During the
last years several studies underline the important role
of a growth hormone, specifically produced by the pla-
centa, the placental growth hormone [18]. This hor-
mone, product of GH-V gene, expressed specifically in
the syncytiotrophoblast, differs from the pituitary
growth hormone by 13 amino acids. It gradually
replaces in the maternal circulation, the pituitary
growth hormone, which becomes undetectable during
the second trimester of pregnancy. Secreted continu-
ously by the placenta, it seems to control the synthesis
of maternal IGF-1. Indeed, maternal IGF1 levels are
correlated with placental GH levels. This suggests a
metabolic role of placental growth hormone, directly
involved in the insulino resistance of pregnancy. Pla-
cental GH is secreted specifically in the maternal com-
partment and not detected in fetal circulation. Recent-
ly this hormone was shown to be involved in the com-
plex mechanisms which regulate trophobast invasion
into the maternal uterine wall. Indeed placental GH
secreted by the invasive trophoblast increases tro-
phoblast invasion by an autocrine/paracrine mecha-
nisms [19]. The syncytiotrophoblast also secretes other
peptide hormones whose maternal levels increase
gradually throughout pregnancy thus reflecting the
progressive increase of the syncytiotrophoblastic
mass. It is the case of inhibin A and activin A [20] as
well as leptin [21] and resistin [22]. 
The human placenta is the site of an important pro-
duction of steroid hormones, which are mainly proges-
terone and estrogens: estriol, estradiol and estrone. At
term, the daily placental production of progesterone is
about 300 mg [23]. Progesterone acts essentially on
the uterus and is required for myometrium quiescence.
During the first six weeks of pregnancy, the production
of progesterone is primarily carried out by the gravidic
ovary corpus luteum. It is thus associated with a secre-
tion of 17αhydroxy progesterone, produced exclusive-
ly by the ovary at this stage of pregnancy. The placen-
tal progesterone production gradually takes over with
the appearance within the syncytiotrophoblast of the
various enzymatic systems necessary for its synthesis.
Interestingly some of these enzymes are induced by
oxygen. Therefore as soon as 10 weeks of pregnancy
when the trophoblastic plugs start to delete, the syn-
thesis of progesterone is high enough to maintain preg-
nancy in case of ovariectomy. The precursor of prog-
esterone is cholesterol. The de novo synthesis of cho-
lesterol from acetyl CoA is not significant in the pla-
centa. The maternal origin of placental cholesterol has
been demonstrated; the trophoblast captures choles-
terol carried by maternal plasmatic lipoproteins.
Indeed, second and third trimesters of pregnancy are
characterized by high levels of maternal circulating
total cholesterol, triglycerids, low-density lipoproteins
(LDL cholesterol) and high-density lipoproteins (HDL
cholesterol). The syncytiotrophoblast apical microvil-
lous membrane, in direct contact with maternal blood
presents specific receptors for these lipoproteins (LDL
receptor, VLDL receptor, B1 scavenger receptor). It
captures and metabolizes LDL by these specific recep-
tor mediated endocytosis. After internalization LDL
are degraded in the lysosomes to release cholesterol,
which will be used for steroidogenesis, and cellular
membranes synthesis. Free cholesterol is then trans-
ported by the Sterol Carrier Protein-2 (SCP2) to the
external membrane of the mitochondria and then to the
internal membrane by the MLN64 (metastatic lymph
node 64). MLN64 presents a final domain similar to
the stAR(steroidogenic acute regulatory protein), a
protein expressed in the other steroidogenic tissues
(corpus luteum, adrenals) [24]. In the internal mem-
brane of the mitochondria, P-450 cytochrome scc
(cholesterol side chain cleavage), allows the conver-
sion of cholesterol into pregnenolone. This reaction
requires electrons provided by the mitochondrial
adrenodoxin (ADX) and adrenodoxin reductase
(AdRed) activities. Only one gene (P-450XIA) coding
for P-450scc and localized on chromosome 15 is pres-
ent in the placenta, as soon as the 10th week of preg-
nancy. Pregnenolone is then converted into proges-
terone by the 3βhydroxysteroid-deshydrogenase/iso-
merase (3β HSD) localized also in mitochondria. Sev-
eral genes coding for different 3β HSD isoforms are
described. In the placenta, only the type 1 gene is
expressed. For estrogen synthesis, in contrast to other
steroidogenic organ, the placenta does not express the
cytochrome P450 17α-hydroxylase-17:20 lyase, and
therefore cannot convert pregnenolone and proges-
terone into androgens. Thus the production of placen-
tal estrogens is tributary of a precursor androgen, the
sulphate of dehydroepiandrosterone (S-DHA) pro-
duced by the maternal and fetal adrenal glands. During
pregnancy the estrogen synthesis from fetal adrenal
glands origin increases progressively. The S-DHA dif-
fuses from fetal blood to the syncytiotrophoblast and is
hydrolized by a sterol steroid sulfatase; DHA is then
metabolized in androstendione by a 3β HSD. Andros-
tendione is transformed into testosterone by a 17 βhy-
droxysteroid dehydrogenase (17 βHSD) encoded by a
gene, HSD17B1, localized on chromosome 17 (17q11-
q21). C19 androsterone and testosterone are then aro-
matized in C18 estrogens (estrone and estradiol
respectively) by the P450 cytochrome aromatase,
encoded by CYP19 gene, only present in the syncy-
tiotrophoblast. Fetal adrenal S-DHA can also undergo
16α-hydroxylation in the fetal liver leading to the for-
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mation of 16α-hydroxy S-DHA, the estriol androgen
precursor. Thus 90% of placental estriol arises from
fetal adrenal glands and liver activities. This coopera-
tion between the placenta and the fetus has led to the
concept of fetoplacental unit (Fig. 4). If numerous fac-
tors such as hCG, cAMP, prostaglandins, have been
described to modulate in vitro placental estrogen syn-
thesis, the quality of fetal adrenal glands development
remains the essential factor. 
If progesterone is absolutely required for the well
being of pregnancy, the role of estrogens remains still
uncertain. Indeed genetic deficiencies in placental sul-
fatase or aromatase, leading to very low levels of
maternal circulating estrogens are associated with nor-
mal pregnancy. 
Conclusion
The human placenta has numerous developmental and
endocrine particularities. Therefore investigators must
keep in mind the limitation of each experimental mod-
els. During the first trimester of pregnancy, which
occurs in a low oxygen environment, the invasive tro-
phoblast secretes a large amount of hormones directly
involved in the quality of the placentation. After 10-12
weeks of pregnancy, the endocrine trophoblast bathing
in maternal blood secretes numerous hormones which
take over the maternal metabolism in order to increase
the energetic flux to the fetus. 
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